首页 > 最新文献

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy最新文献

英文 中文
Immunoabsorption Therapy for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Retrospective Study. 髓鞘少突胶质细胞糖蛋白抗体相关疾病的免疫吸收治疗:一项回顾性研究
Dongxue Wang, Yunjin Xiong, Jing Liu, Yiduo Feng, Changqin Zhang, Yin Zhang, Xia Ding, Xiaoyuan Wu, Akehu Alemasi, Qi Huang, Yu Wu, Huabing Wang, Yong Gong, De-Cai Tian, Yilun Zhou

Introduction: The elimination of myelin oligodendrocyte glycoprotein (MOG) antibodies using immunoadsorption (IA) is a therapeutic approach, but has not yet been specifically evaluated in MOG antibody-associated disease (MOGAD). This study aimed to provide evidence on the efficacy and safety of IA therapy for MOGAD.

Methods: This retrospective study included patients diagnosed with MOGAD, who were treated with IA. Clinical data of the patients were collected. The extended disability score scale (EDSS) before and after IA therapy was used to evaluate neurological status.

Results: Six patients aged 14-53 years were enrolled in this study. Each patient received 3-7 sessions of IA therapy. Half of the patients showed significant clinical improvement after IA, with EDSS scores decreasing by more than 1.0, whereas the other patients were unresponsive to IA. Partial remission of visual acuity was obtained in three of the four patients with visual impairment. Repeated detection of MOG antibodies in one case showed that the titer declined from 1:100 to 1:32 after five sessions of IA. Only one episode of mild hypotension was observed in 29 IA sessions.

Conclusion: IA therapy may be a potential treatment option for patients with MOGAD.

使用免疫吸附(IA)消除髓鞘少突胶质细胞糖蛋白(MOG)抗体是一种治疗方法,但尚未在MOG抗体相关疾病(MOGAD)中进行专门评估。本研究旨在为IA治疗MOGAD的有效性和安全性提供证据。方法:本回顾性研究纳入诊断为MOGAD并接受IA治疗的患者。收集患者的临床资料。采用扩展失能评分量表(EDSS)评估IA治疗前后的神经功能状态。结果:6例年龄14-53岁的患者入组研究。每例患者接受3-7次IA治疗。一半患者在IA后临床表现明显改善,EDSS评分下降1.0以上,而其他患者对IA无反应。4例视力障碍患者中有3例视力部分缓解。1例MOG抗体重复检测显示,5次IA后滴度从1:100下降到1:32。在29个IA疗程中只观察到1次轻度低血压。结论:IA治疗可能是MOGAD患者的一种潜在治疗选择。
{"title":"Immunoabsorption Therapy for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Retrospective Study.","authors":"Dongxue Wang, Yunjin Xiong, Jing Liu, Yiduo Feng, Changqin Zhang, Yin Zhang, Xia Ding, Xiaoyuan Wu, Akehu Alemasi, Qi Huang, Yu Wu, Huabing Wang, Yong Gong, De-Cai Tian, Yilun Zhou","doi":"10.1111/1744-9987.70063","DOIUrl":"10.1111/1744-9987.70063","url":null,"abstract":"<p><strong>Introduction: </strong>The elimination of myelin oligodendrocyte glycoprotein (MOG) antibodies using immunoadsorption (IA) is a therapeutic approach, but has not yet been specifically evaluated in MOG antibody-associated disease (MOGAD). This study aimed to provide evidence on the efficacy and safety of IA therapy for MOGAD.</p><p><strong>Methods: </strong>This retrospective study included patients diagnosed with MOGAD, who were treated with IA. Clinical data of the patients were collected. The extended disability score scale (EDSS) before and after IA therapy was used to evaluate neurological status.</p><p><strong>Results: </strong>Six patients aged 14-53 years were enrolled in this study. Each patient received 3-7 sessions of IA therapy. Half of the patients showed significant clinical improvement after IA, with EDSS scores decreasing by more than 1.0, whereas the other patients were unresponsive to IA. Partial remission of visual acuity was obtained in three of the four patients with visual impairment. Repeated detection of MOG antibodies in one case showed that the titer declined from 1:100 to 1:32 after five sessions of IA. Only one episode of mild hypotension was observed in 29 IA sessions.</p><p><strong>Conclusion: </strong>IA therapy may be a potential treatment option for patients with MOGAD.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"776-781"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144586032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Assessment of Large Language Models in Pediatric Dialysis: Reliability, Quality and Readability. 儿童透析大语言模型的比较评估:可靠性、质量和可读性。
Esra Ensari, Esra Nagehan Akyol Onder, Pelin Ertan

Introduction: This study evaluated the reliability, quality, and readability of ChatGPT (OpenAI, San Francisco, CA), Gemini (Google, Mountain View, CA), and Copilot (Microsoft Corp., Washington, DC) which are among the most widely used large language models (LLMs) today in answering frequently asked questions (FAQs) related to pediatric dialysis.

Methods: A total of 45 FAQs were entered into LLM. The Modified DISCERN (mDISCERN) scale assessed reliability; the Global Quality Score (GQS) evaluated quality; and readability was assessed using five metrics: Coleman-Liau Index (CLI), Simple Measure of Gobbledygook (SMOG), Gunning Fog Index (GFI), Flesch Reading Ease (FRE) and Flesch-Kincaid Grade Level (FKGL). Questions were directed to the chat robots twice, on January 25, 2025, and February 1, 2025.

Results: All three chatbots displayed high reliability, achieving median mDISCERN scores of 5. Quality scores on the GQS were similarly high, with median scores of 5 across platforms; however, Gemini exhibited greater variability (range 1-5) compared to ChatGPT-4o and Copilot (ranges 3-5). Readability scores revealed that chatbot responses were written at an advanced level.

Conclusion: This study found that LLMs responses to dialysis FAQs were reliable and high quality, but difficult to read; improving readability through expert-reviewed content could increase their impact on public health.

本研究评估了ChatGPT (OpenAI, San Francisco, CA)、Gemini (b谷歌,Mountain View, CA)和Copilot (Microsoft Corp., Washington, DC)的可靠性、质量和可读性,它们是当今在回答与儿科透析相关的常见问题(FAQs)中使用最广泛的大型语言模型(llm)。方法:将45个常见问题录入法学硕士。改进的DISCERN (mDISCERN)量表评估信度;全球质量评分(GQS)评估质量;使用5个指标评估可读性:Coleman-Liau指数(CLI)、简单的官样文章测量(SMOG)、射击雾指数(GFI)、Flesch Reading Ease (FRE)和Flesch- kincaid Grade Level (FKGL)。在2025年1月25日和2025年2月1日,两次向聊天机器人提问。结果:这三个聊天机器人都表现出很高的可靠性,mDISCERN得分中值为5分。GQS的质量得分也同样高,各平台的中位数得分为5分;然而,与chatgpt - 40和Copilot(范围3-5)相比,Gemini表现出更大的变异性(范围1-5)。可读性分数显示,聊天机器人的回复是在高级水平上编写的。结论:本研究发现LLMs对透析常见问题的反应可靠且质量高,但难以阅读;通过专家审查的内容提高可读性可以增加它们对公共卫生的影响。
{"title":"A Comparative Assessment of Large Language Models in Pediatric Dialysis: Reliability, Quality and Readability.","authors":"Esra Ensari, Esra Nagehan Akyol Onder, Pelin Ertan","doi":"10.1111/1744-9987.70058","DOIUrl":"10.1111/1744-9987.70058","url":null,"abstract":"<p><strong>Introduction: </strong>This study evaluated the reliability, quality, and readability of ChatGPT (OpenAI, San Francisco, CA), Gemini (Google, Mountain View, CA), and Copilot (Microsoft Corp., Washington, DC) which are among the most widely used large language models (LLMs) today in answering frequently asked questions (FAQs) related to pediatric dialysis.</p><p><strong>Methods: </strong>A total of 45 FAQs were entered into LLM. The Modified DISCERN (mDISCERN) scale assessed reliability; the Global Quality Score (GQS) evaluated quality; and readability was assessed using five metrics: Coleman-Liau Index (CLI), Simple Measure of Gobbledygook (SMOG), Gunning Fog Index (GFI), Flesch Reading Ease (FRE) and Flesch-Kincaid Grade Level (FKGL). Questions were directed to the chat robots twice, on January 25, 2025, and February 1, 2025.</p><p><strong>Results: </strong>All three chatbots displayed high reliability, achieving median mDISCERN scores of 5. Quality scores on the GQS were similarly high, with median scores of 5 across platforms; however, Gemini exhibited greater variability (range 1-5) compared to ChatGPT-4o and Copilot (ranges 3-5). Readability scores revealed that chatbot responses were written at an advanced level.</p><p><strong>Conclusion: </strong>This study found that LLMs responses to dialysis FAQs were reliable and high quality, but difficult to read; improving readability through expert-reviewed content could increase their impact on public health.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"739-746"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abbreviation usage in nephrology: A nephrologist's perspective. 肾病学中的缩写用法:肾病专家的观点。
Chia-Ter Chao
{"title":"Abbreviation usage in nephrology: A nephrologist's perspective.","authors":"Chia-Ter Chao","doi":"10.1111/1744-9987.70033","DOIUrl":"10.1111/1744-9987.70033","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"808-809"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-to-high-density lipoprotein ratio with diabetic nephropathy". 《中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值、单核细胞-高密度脂蛋白比值与糖尿病肾病的关系》一文评论。
Mostafa Javanian, Mohammad Barary, Soheil Ebrahimpour
{"title":"Commentary on \"Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-to-high-density lipoprotein ratio with diabetic nephropathy\".","authors":"Mostafa Javanian, Mohammad Barary, Soheil Ebrahimpour","doi":"10.1111/1744-9987.70030","DOIUrl":"10.1111/1744-9987.70030","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"806-807"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasmapheresis as rescue therapy for steroid-resistant isolated optic neuritis: A case report. 血浆置换作为类固醇抵抗性孤立性视神经炎的抢救治疗:1例报告。
Eiman Abdel Wahab Fayez Hussein, Mohamed Hussein
{"title":"Plasmapheresis as rescue therapy for steroid-resistant isolated optic neuritis: A case report.","authors":"Eiman Abdel Wahab Fayez Hussein, Mohamed Hussein","doi":"10.1111/1744-9987.70034","DOIUrl":"10.1111/1744-9987.70034","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"800-801"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144062351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Arteriovenous Fistula Creation on GFR Decline. 动静脉造瘘对GFR下降的影响。
Beyza Doğan, Fatih Ergül, Mikail Dağ, Süleyman Karaköse, İbrahim Güney

Purpose: Chronic kidney disease (CKD) poses a significant public health challenge, severely affecting patients' quality of life. The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend discussing renal replacement therapy options when patients reach CKD stage 4. Arteriovenous fistula (AVF) creation is considered the gold standard for vascular access in hemodialysis. This retrospective study aims to evaluate whether any changes in kidney function occur during the follow-up period after AVF creation in patients with end-stage kidney disease (ESKD).

Methods: We analyzed data from 60 CKD patients who underwent AVF creation and were monitored in our nephrology outpatient clinics. Seventeen patients who consistently attended follow-up visits were included for detailed analysis. We performed a retrospective review of laboratory and medical records from 6 months before and 6 months following AVF creation.

Results: The cohort comprised 41.2% males, with a mean age of 62.4 years. The predominant underlying conditions were diabetes mellitus (58.8%), hypertension (29.4%), and polycystic kidney disease (11.8%). Statistical analysis of laboratory values before and after AVF creation (at 1, 3, and 6 months) revealed a significant decline in estimated glomerular filtration rate (eGFR) before AVF placement, followed by stabilization in the subsequent 6 months.

Conclusion: The rate of eGFR decline was significantly reduced in CKD patients with AVF. This may be attributed to increased awareness of impending hemodialysis, leading to better dietary adherence and treatment compliance.

目的:慢性肾脏疾病(CKD)是一项重大的公共卫生挑战,严重影响患者的生活质量。肾脏疾病预后质量倡议(KDOQI)指南建议在患者达到CKD 4期时讨论肾脏替代治疗方案。动静脉瘘(AVF)的产生被认为是血液透析血管通路的金标准。本回顾性研究旨在评估终末期肾病(ESKD)患者在AVF形成后的随访期间肾功能是否发生任何变化。方法:我们分析了60例CKD患者的数据,这些患者接受了AVF的创建,并在我们的肾内科门诊进行了监测。17例持续参加随访的患者被纳入详细分析。我们对AVF创建前6个月和后6个月的实验室和医疗记录进行了回顾性审查。结果:男性占41.2%,平均年龄62.4岁。主要基础疾病为糖尿病(58.8%)、高血压(29.4%)和多囊肾病(11.8%)。AVF创建前后(1、3和6个月)的实验室值统计分析显示,AVF放置前估计的肾小球滤过率(eGFR)显著下降,随后6个月趋于稳定。结论:CKD合并AVF患者eGFR下降率明显降低。这可能是由于对即将到来的血液透析的认识增加,导致更好的饮食依从性和治疗依从性。
{"title":"The Effect of Arteriovenous Fistula Creation on GFR Decline.","authors":"Beyza Doğan, Fatih Ergül, Mikail Dağ, Süleyman Karaköse, İbrahim Güney","doi":"10.1111/1744-9987.70054","DOIUrl":"10.1111/1744-9987.70054","url":null,"abstract":"<p><strong>Purpose: </strong>Chronic kidney disease (CKD) poses a significant public health challenge, severely affecting patients' quality of life. The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend discussing renal replacement therapy options when patients reach CKD stage 4. Arteriovenous fistula (AVF) creation is considered the gold standard for vascular access in hemodialysis. This retrospective study aims to evaluate whether any changes in kidney function occur during the follow-up period after AVF creation in patients with end-stage kidney disease (ESKD).</p><p><strong>Methods: </strong>We analyzed data from 60 CKD patients who underwent AVF creation and were monitored in our nephrology outpatient clinics. Seventeen patients who consistently attended follow-up visits were included for detailed analysis. We performed a retrospective review of laboratory and medical records from 6 months before and 6 months following AVF creation.</p><p><strong>Results: </strong>The cohort comprised 41.2% males, with a mean age of 62.4 years. The predominant underlying conditions were diabetes mellitus (58.8%), hypertension (29.4%), and polycystic kidney disease (11.8%). Statistical analysis of laboratory values before and after AVF creation (at 1, 3, and 6 months) revealed a significant decline in estimated glomerular filtration rate (eGFR) before AVF placement, followed by stabilization in the subsequent 6 months.</p><p><strong>Conclusion: </strong>The rate of eGFR decline was significantly reduced in CKD patients with AVF. This may be attributed to increased awareness of impending hemodialysis, leading to better dietary adherence and treatment compliance.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"747-751"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144287644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Clinical efficacy of low molecular weight heparin and insulin combined with plasma exchange in treating hyperlipidemic acute pancreatitis: A randomized controlled study. 致编辑:低分子肝素和胰岛素联合血浆置换治疗高脂血症急性胰腺炎的临床疗效:一项随机对照研究。
Muhammad Farhan Khan, Hina Khan, Faraz Iqbal
{"title":"Letter to the Editor: Clinical efficacy of low molecular weight heparin and insulin combined with plasma exchange in treating hyperlipidemic acute pancreatitis: A randomized controlled study.","authors":"Muhammad Farhan Khan, Hina Khan, Faraz Iqbal","doi":"10.1111/1744-9987.70029","DOIUrl":"10.1111/1744-9987.70029","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"798-799"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144036475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ionized Calcium Before Venous Bubble Trap Strongly Affects Coagulation When Using Calcium-Containing Dialysate in Regional Citrate Anticoagulation for Intermittent Hemodialysis: A Real-World Prospective Study. 一项真实世界的前瞻性研究:在间歇性血液透析中使用含钙透析液进行局部柠檬酸抗凝治疗时,静脉泡陷阱前的离子钙强烈影响凝血。
Zhen Ai, Lijun Luo, Wenhao Li, Haishan Wu, Lian Zhao, Raoping Wang, Dihua Zhang, Suiqin Wen, Yuanwen Xu

Introduction: Regional citrate anticoagulation (RCA) is highly recommended as an anticoagulation method for intermittent hemodialysis (IHD) in patients at high bleeding risk. Few studies have investigated the effect of ionized calcium (iCa) concentration at different pipeline points on circuit clotting in RCA using calcium-containing dialysate.

Methods: This prospective study included 185 IHD sessions treated with a two-stage RCA protocol. Ionized calcium levels were measured at different pipeline points. The primary endpoint was severe clotting in the extracorporeal circulation circuit (ECC).

Results: Sessions with severe circuit clotting showed higher platelet counts, shorter activated partial thromboplastin time, greater dialyzer surface areas, and higher iCa concentrations around venous bubble trap (VBT). Cox regression models revealed that iCa concentration before VBT (per 0.10 mmol/L, hazard ratio (HR) = 1.54, p = 0.006) and baseline platelet count (HR = 1.01, p = 0.02) were strongly associated with severe circuit clotting.

Conclusion: The iCa concentration before VBT could serve as a key indicator of anticoagulant efficacy in RCA with calcium-containing dialysate.

引言:局部柠檬酸抗凝(RCA)被强烈推荐作为间歇性血液透析(IHD)高危患者的抗凝方法。很少有研究研究了不同管道点的离子钙(iCa)浓度对含钙透析液RCA回路凝血的影响。方法:这项前瞻性研究包括185例IHD患者,采用两阶段RCA治疗方案。在不同的管道点测量离子钙水平。主要终点是体外循环回路(ECC)严重凝血。结果:严重的循环凝血表现出更高的血小板计数,更短的激活部分凝血活素时间,更大的透析器表面积,以及静脉泡陷阱(VBT)周围更高的iCa浓度。Cox回归模型显示,VBT前iCa浓度(每0.10 mmol/L,风险比(HR) = 1.54, p = 0.006)和基线血小板计数(HR = 1.01, p = 0.02)与严重血栓形成密切相关。结论:VBT前iCa浓度可作为含钙透析液RCA抗凝效果的关键指标。
{"title":"Ionized Calcium Before Venous Bubble Trap Strongly Affects Coagulation When Using Calcium-Containing Dialysate in Regional Citrate Anticoagulation for Intermittent Hemodialysis: A Real-World Prospective Study.","authors":"Zhen Ai, Lijun Luo, Wenhao Li, Haishan Wu, Lian Zhao, Raoping Wang, Dihua Zhang, Suiqin Wen, Yuanwen Xu","doi":"10.1111/1744-9987.70055","DOIUrl":"10.1111/1744-9987.70055","url":null,"abstract":"<p><strong>Introduction: </strong>Regional citrate anticoagulation (RCA) is highly recommended as an anticoagulation method for intermittent hemodialysis (IHD) in patients at high bleeding risk. Few studies have investigated the effect of ionized calcium (iCa) concentration at different pipeline points on circuit clotting in RCA using calcium-containing dialysate.</p><p><strong>Methods: </strong>This prospective study included 185 IHD sessions treated with a two-stage RCA protocol. Ionized calcium levels were measured at different pipeline points. The primary endpoint was severe clotting in the extracorporeal circulation circuit (ECC).</p><p><strong>Results: </strong>Sessions with severe circuit clotting showed higher platelet counts, shorter activated partial thromboplastin time, greater dialyzer surface areas, and higher iCa concentrations around venous bubble trap (VBT). Cox regression models revealed that iCa concentration before VBT (per 0.10 mmol/L, hazard ratio (HR) = 1.54, p = 0.006) and baseline platelet count (HR = 1.01, p = 0.02) were strongly associated with severe circuit clotting.</p><p><strong>Conclusion: </strong>The iCa concentration before VBT could serve as a key indicator of anticoagulant efficacy in RCA with calcium-containing dialysate.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"730-738"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peritoneal Lavage With Low GDP Neutral pH PD Solution Reduces Mortality and Severity in a Lethal Peritonitis Model. 低GDP中性pH PD溶液腹腔灌洗可降低致死性腹膜炎模型的死亡率和严重程度。
Masato Ikeda, Kotaro Haruhara, Yukio Maruyama, Naoko Tanaka, Risa Kusanagi, Yuri Sakamaki, Hitomi Hagiwara, Takashi Yokoo

Introduction: The efficacy of peritoneal lavage monotherapy using PD solution for severe peritonitis remains unproven.

Methods: We evaluated the effects of 3-times and 6-times lavage using low GDP neutral PD solution on a Methicillin-sensitive Staphylococcus aureus (MSSA) lethal peritonitis model rats without antibiotic use. Changes in effluent viable bacteria numbers dependent on lavage frequency were determined in a further 10 rats.

Results: Compared to the lethal peritonitis model without lavage, both 3-times and 6-times lavage significantly reduced 24-h mortality, effluent FDP and creatinine concentrations. Furthermore, 6-times lavage significantly prevented the rough fur development, intraabdominal adhesion, and pus formation which developed in both the 0-times and 3-times lavage groups. The effluent viable bacterial counts showed significant step-ladder decreases with an increasing number of the lavages.

Conclusion: We demonstrated for the first time that lavage monotherapy using PD solution reduces mortality and severity in a lethal peritonitis model by rapidly eliminating bacteria without antibiotic use.

腹膜灌洗单药PD液治疗严重腹膜炎的疗效尚未得到证实。方法:观察低GDP中性PD溶液灌洗3次和6次对不使用抗生素的甲氧西林敏感金黄色葡萄球菌(MSSA)致死性腹膜炎模型大鼠的影响。在另外10只大鼠中测定了出水活菌数量随灌洗频率的变化。结果:与未灌洗的致死性腹膜炎模型相比,灌洗3次和6次均显著降低24h死亡率、出水FDP和肌酐浓度。此外,6次灌洗对0次和3次灌洗组小鼠毛糙、腹腔粘连和脓形成均有显著抑制作用。随着冲洗次数的增加,出水活菌数呈阶梯状显著下降。结论:我们首次证明,在不使用抗生素的情况下,使用PD溶液单药灌洗可以快速清除细菌,从而降低致死性腹膜炎模型的死亡率和严重程度。
{"title":"Peritoneal Lavage With Low GDP Neutral pH PD Solution Reduces Mortality and Severity in a Lethal Peritonitis Model.","authors":"Masato Ikeda, Kotaro Haruhara, Yukio Maruyama, Naoko Tanaka, Risa Kusanagi, Yuri Sakamaki, Hitomi Hagiwara, Takashi Yokoo","doi":"10.1111/1744-9987.70061","DOIUrl":"10.1111/1744-9987.70061","url":null,"abstract":"<p><strong>Introduction: </strong>The efficacy of peritoneal lavage monotherapy using PD solution for severe peritonitis remains unproven.</p><p><strong>Methods: </strong>We evaluated the effects of 3-times and 6-times lavage using low GDP neutral PD solution on a Methicillin-sensitive Staphylococcus aureus (MSSA) lethal peritonitis model rats without antibiotic use. Changes in effluent viable bacteria numbers dependent on lavage frequency were determined in a further 10 rats.</p><p><strong>Results: </strong>Compared to the lethal peritonitis model without lavage, both 3-times and 6-times lavage significantly reduced 24-h mortality, effluent FDP and creatinine concentrations. Furthermore, 6-times lavage significantly prevented the rough fur development, intraabdominal adhesion, and pus formation which developed in both the 0-times and 3-times lavage groups. The effluent viable bacterial counts showed significant step-ladder decreases with an increasing number of the lavages.</p><p><strong>Conclusion: </strong>We demonstrated for the first time that lavage monotherapy using PD solution reduces mortality and severity in a lethal peritonitis model by rapidly eliminating bacteria without antibiotic use.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"752-759"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144602711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers Related to Peritoneal Transfer Function and Dialysis Adequacy. 与腹膜转移功能和透析充分性相关的生物标志物。
Shuyi Pu, Shiyi Song, Xiaomin Jia, Ji Wang

The main treatment for end-stage renal disease (ESRD) is renal replacement therapy, among which peritoneal dialysis (PD) is easy to perform, inexpensive, and widely used. The internationally adopted Peritoneal Equilibration Test (PET) categorizes peritoneal function into four types based on the dialysate-to-plasma creatinine ratio (D/Pcr). In some patients undergoing long-term PD, changes in peritoneal function lead to a decline in dialysis adequacy, which ultimately results in withdrawal from PD. Among these patients, those with high-transport peritoneal function exhibit higher mortality rates and poorer prognoses compared to patients with low-transport peritoneal function. However, PET fails to identify underlying pathologies (e.g., fibrosis, inflammation). Similarly, dialysis adequacy tests also fail to reveal the underlying causes of changes in dialysis adequacy. Therefore, early identification of the underlying causes of peritoneal function changes and timely clinical interventions may prolong the duration of PD. This review lists biomarkers related to peritoneal transport function that may indicate the causes of altered peritoneal function and could guide clinical treatment protocols in the future.

终末期肾病(ESRD)的主要治疗方法是肾脏替代疗法,其中腹膜透析(PD)操作简单,价格低廉,应用广泛。国际上采用的腹膜平衡试验(PET)根据透析液与血浆肌酐比值(D/Pcr)将腹膜功能分为四种类型。在一些长期PD的患者中,腹膜功能的改变导致透析充分性下降,最终导致退出PD治疗。在这些患者中,与低转运腹膜功能患者相比,具有高转运腹膜功能的患者表现出更高的死亡率和更差的预后。然而,PET不能识别潜在的病理(如纤维化、炎症)。同样,透析充分性测试也不能揭示透析充分性变化的根本原因。因此,早期发现腹膜功能改变的根本原因并及时进行临床干预可能会延长PD的病程。这篇综述列出了与腹膜转运功能相关的生物标志物,这些生物标志物可能表明腹膜功能改变的原因,并可以指导未来的临床治疗方案。
{"title":"Biomarkers Related to Peritoneal Transfer Function and Dialysis Adequacy.","authors":"Shuyi Pu, Shiyi Song, Xiaomin Jia, Ji Wang","doi":"10.1111/1744-9987.70052","DOIUrl":"10.1111/1744-9987.70052","url":null,"abstract":"<p><p>The main treatment for end-stage renal disease (ESRD) is renal replacement therapy, among which peritoneal dialysis (PD) is easy to perform, inexpensive, and widely used. The internationally adopted Peritoneal Equilibration Test (PET) categorizes peritoneal function into four types based on the dialysate-to-plasma creatinine ratio (D/Pcr). In some patients undergoing long-term PD, changes in peritoneal function lead to a decline in dialysis adequacy, which ultimately results in withdrawal from PD. Among these patients, those with high-transport peritoneal function exhibit higher mortality rates and poorer prognoses compared to patients with low-transport peritoneal function. However, PET fails to identify underlying pathologies (e.g., fibrosis, inflammation). Similarly, dialysis adequacy tests also fail to reveal the underlying causes of changes in dialysis adequacy. Therefore, early identification of the underlying causes of peritoneal function changes and timely clinical interventions may prolong the duration of PD. This review lists biomarkers related to peritoneal transport function that may indicate the causes of altered peritoneal function and could guide clinical treatment protocols in the future.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"713-720"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144287642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1